 Therapeutic defibrination ancrod canine myocardium reperfusion injury purpose study normal fibrinogen contributes development myocardial reperfusion injury substrate vivo neutrophil adhesion dog model acute myocardial infarction pentobarbital anesthetized dogs min regional myocardial ischemia reperfusion Dogs unit/kg Ancrod venom Malayan pit viper Agkistrodon rhodostoma vehicle i.v min circumflex coronary artery occlusion Therapeutic defibrination Ancrod-treated dogs measurements clottable fibrinogen antiplasmin plasminogen partial thromboplastin time immunoelectrophoresis Fibrinogen detectable limits assay mg/ml treatment Ancrod defibrination effect expected activation fibrinolytic system antiplasmin plasminogen activity Ancrod treatment measureable differences treatment groups heart rate arterial blood pressure rate pressure product circumflex coronary blood flow min regional ischemia reperfusion relative severity ischemia treatment groups similar microsphere measurement myocardial blood flow accumulation neutrophils myeloperoxidase activity myocardium reperfusion prior depletion fibrinogen